FAS Wealth Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13M | Buy |
10,858
+443
| +4% | +$453K | 0.68% | 35 |
|
|
2026
Q1 | $9.58M | Buy |
10,415
+350
| +3% | +$355K | 0.6% | 44 |
|
|
2025
Q4 | $10.8M | Buy |
10,065
+291
| +3% | +$278K | 0.7% | 34 |
|
|
2025
Q3 | $7.46M | Buy |
9,774
+235
| +2% | +$175K | 0.51% | 44 |
|
|
2025
Q2 | $7.44M | Buy |
9,539
+574
| +6% | +$446K | 0.55% | 41 |
|
|
2025
Q1 | $7.4M | Buy |
8,965
+109
| +1% | +$90.7K | 0.6% | 40 |
|
|
2024
Q4 | $6.84M | Buy |
8,856
+3,218
| +57% | +$2.66M | 0.57% | 41 |
|
|
2024
Q3 | $4.99M | Buy |
5,638
+109
| +2% | +$98K | 0.4% | 57 |
|
|
2024
Q2 | $5.01M | Buy |
5,529
+93
| +2% | +$74.4K | 0.43% | 54 |
|
|
2024
Q1 | $4.23M | Sell |
5,436
-75
| -1% | -$53.4K | 0.37% | 61 |
|
|
2023
Q4 | $3.21M | Buy |
5,511
+103
| +2% | +$60.1K | 0.31% | 74 |
|
|
2023
Q3 | $2.9M | Buy |
5,408
+140
| +3% | +$72.1K | 0.31% | 73 |
|
|
2023
Q2 | $2.47M | Sell |
5,268
-623
| -11% | -$261K | 0.31% | 74 |
|
|
2023
Q1 | $2.02M | Buy |
5,891
+3
| +0.1% | +$1.01K | 0.22% | 96 |
|
|
2022
Q4 | $2.15M | Sell |
5,888
-7
| -0.1% | -$2.48K | 0.24% | 90 |
|
|
2022
Q3 | $1.91M | Buy |
5,895
+950
| +19% | +$301K | 0.21% | 84 |
|
|
2022
Q2 | $1.6M | Sell |
4,945
-85
| -2% | -$25.5K | 0.17% | 92 |
|
|
2022
Q1 | $1.44M | Buy |
5,030
+4
| +0.1% | +$1.03K | 0.14% | 101 |
|
|
2021
Q4 | $1.39M | Sell |
5,026
-16
| -0.3% | -$4.06K | 0.13% | 104 |
|
|
2021
Q3 | $1.17M | Sell |
5,042
-86
| -2% | -$21.2K | 0.11% | 117 |
|
|
2021
Q2 | $1.18M | Buy |
5,128
+4
| +0.1% | +$803 | 0.11% | 117 |
|
|
2021
Q1 | $957K | Buy |
5,124
+805
| +19% | +$157K | 0.1% | 127 |
|
|
2020
Q4 | $729K | Sell |
4,319
-10
| -0.2% | -$1.49K | 0.08% | 140 |
|
|
2020
Q3 | $641K | Sell |
4,329
-225
| -5% | -$34.8K | 0.09% | 142 |
|
|
2020
Q2 | $748K | Sell |
4,554
-194
| -4% | -$29.8K | 0.11% | 124 |
|
|
2020
Q1 | $659K | Buy |
4,748
+4
| +0.1% | +$550 | 0.12% | 117 |
|
|
2019
Q4 | $624K | Buy |
4,744
+111
| +2% | +$12.9K | 0.11% | 125 |
|
|
2019
Q3 | $518K | Buy |
4,633
+3
| +0.1% | +$334 | 0.09% | 129 |
|
|
2019
Q2 | $513K | Buy |
4,630
+3
| +0.1% | +$353 | 0.1% | 129 |
|
|
2019
Q1 | $600K | Sell |
4,627
-144
| -3% | -$17.5K | 0.12% | 115 |
|
|
2018
Q4 | $552K | Sell |
4,771
-202
| -4% | -$22.6K | 0.13% | 116 |
|
|
2018
Q3 | $534K | Buy |
4,973
+2
| +0% | +$200 | 0.12% | 110 |
|
|
2018
Q2 | $424K | Buy |
4,971
+4
| +0.1% | +$329 | 0.11% | 124 |
|
|
2018
Q1 | $384K | Sell |
4,967
-201
| -4% | -$16.2K | 0.11% | 128 |
|
|
2017
Q4 | $436K | Sell |
5,168
-322
| -6% | -$27.4K | 0.11% | 119 |
|
|
2017
Q3 | $470K | Sell |
5,490
-597
| -10% | -$49K | 0.13% | 112 |
|
|
2017
Q2 | $501K | Buy |
6,087
+3
| +0% | +$245 | 0.15% | 92 |
|
|
2017
Q1 | $512K | Buy |
6,084
+103
| +2% | +$8.25K | 0.16% | 92 |
|
|
2016
Q4 | $440K | Buy |
5,981
+4
| +0.1% | +$298 | 0.13% | 98 |
|
|
2016
Q3 | $480K | Buy |
5,977
+3
| +0.1% | +$240 | 0.16% | 84 |
|
|
2016
Q2 | $470K | Sell |
5,974
-997
| -14% | -$75.1K | 0.17% | 81 |
|
|
2016
Q1 | $502K | Sell |
6,971
-1,447
| -17% | -$109K | 0.26% | 49 |
|
|
2015
Q4 | $709K | Buy |
8,418
+3
| +0% | +$249 | 0.35% | 40 |
|
|
2015
Q3 | $704K | Sell |
8,415
-97
| -1% | -$8.19K | 0.41% | 32 |
|
|
2015
Q2 | $711K | Buy |
8,512
+152
| +2% | +$11.6K | 0.36% | 33 |
|
|
2015
Q1 | $607K | Buy |
8,360
+2
| +0% | +$142 | 0.31% | 34 |
|
|
2014
Q4 | $577K | Sell |
8,358
-778
| -9% | -$52.5K | 0.3% | 34 |
|
|
2014
Q3 | $592K | Sell |
9,136
-18
| -0.2% | -$1.14K | 0.34% | 27 |
|
|
2014
Q2 | $569K | Sell |
9,154
-515
| -5% | -$30.7K | 0.33% | 28 |
|
|
2014
Q1 | $569K | Sell |
9,669
-498
| -5% | -$27.8K | 0.39% | 23 |
|
|
2013
Q4 | $519K | Buy |
+10,167
| New | +$509K | 0.31% | 26 |
|
Other funds holding LLY
FAS Wealth Partners's LLY Position: Q2 2026 in Review
FAS Wealth Partners increased its Eli Lilly (LLY) stake by 4.3% in Q2 2026, buying an estimated $453K and bringing the position to 10,858 shares worth $13M. The position accounts for 0.68% of the portfolio, ranked #35.
FAS Wealth Partners first reported a position in LLY in Q4 2013 and has held it in 51 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- FAS Wealth Partners held 10,858 shares of Eli Lilly worth $13M as of Q2 2026.
- FAS Wealth Partners bought 443 Eli Lilly shares in Q2 2026, an estimated $453K.
- Eli Lilly made up 0.68% of FAS Wealth Partners's portfolio in Q2 2026, its #35 holding.
- FAS Wealth Partners first reported a position in Eli Lilly in Q4 2013 and has held it in 51 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on FAS Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.